IN CANCER CLINICAL TRIALS^ADAPTATION OF DABYL REPEATABLE RADIOTHERAPY, AND REDUCE THERAPIST SETUP TIMES.

IN CANCER CLINICAL TRIALS^ADAPTATION OF DABYL REPEATABLE RADIOTHERAPY, AND REDUCE THERAPIST SETUP TIMES.TRIPOS IS THE LEADING SUPPLIER OF INTERACTIVE 3-D GRAPHICS-BASED MOLECULAR MODELING SOFTWARE, USED PRIMARILY IN PHARMACEUTICAL RESEARCH. IN COLLABORATION WITH JERI1, TRIPOS HAS ALSO BEEN DEVELOPING AN INTERACTIVE 3-D GRAPHICS-BASED STATISTICAL SOFTWARE PACKAGE, PROVISIONALLY KNOWN AS DABYL, WHICH HAS MANY OF THE STATE-OF-THE-ART FEATURES NCI REQUIRES FOR CANCER CLINICAL TRIALS. PHASE I WOULD EXPLORE THE FEASIBILITY OF EXTENDING DABYL'S CAPABILITIES BEYOND THOSE NEEDED FOR ITS PRIMARY MARKET, MULTIVARIATE CHEMOMETRICS 1.ADDITION OF ANALYTICAL METHODS PECULIAR TO CANCER CLINICAL TRIALS; 2.DESIGN OF A ""COMMAND MONITOR'' CAPABLE OF BUILDING AND MANIPULATING A STACK OF DYNAMIC VARIABLES, THEREBY IMPARTING A MORE S-LIKE FLAVOR TO DABYL; 3.IMPLEMENTATION OF A GENERALIZED DATABASE INTERFACE FOR DABYL; 4.DEMONSTRATION THAT DABYL CAN BE PORTED FROM VAX/VMS TO A 32-BIT SUPERMICRO.